← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2006Last known activity
Dec 5, 2023
Timeline
1870s
- Jan 1, 1879
Tokyo Metropolitan Komagome Hospital— Founded
Drugs by trial phase (11 distinct, 8 trials)
Phase 2 (11 own, 0 via acquisition)
Indications
Studied for
- Cholangitis
- Fibrosis
- Hemophilia A
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Myelodysplastic Syndromes
- Neoplasms
- Pancreatic Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recent trials (18)
- NCT06144086Lead sponsorPhase 2Dec 5, 2023
- NCT06144086Overall official - principal investigatorPhase 2Dec 5, 2023
- NCT06144086Sponsor investigatorPhase 2Dec 5, 2023
- NCT04688034Sponsor investigatorPhase 1Jan 15, 2021
- NCT04688034Lead sponsorPhase 1Jan 15, 2021
- NCT04688034Overall official - principal investigatorPhase 1Jan 15, 2021
- NCT04047160Overall official - principal investigatorPhase 1Aug 29, 2019
- NCT04047160Lead sponsorPhase 1Aug 29, 2019
- NCT04047160Reponsible party - principal investigatorPhase 1Aug 29, 2019
- NCT03620474Reponsible party - principal investigatorPhase 1/Phase 2Jul 24, 2018
- NCT03620474Lead sponsorPhase 1/Phase 2Jul 24, 2018
- NCT03620474Overall official - principal investigatorPhase 1/Phase 2Jul 24, 2018
- NCT02195440Overall official - principal investigatorPhase 1Aug 1, 2014
- NCT02195440Reponsible party - principal investigatorPhase 1Aug 1, 2014
- NCT02195440Lead sponsorPhase 1Aug 1, 2014
Details
- Founded
- Tokyo, JP Jan 1, 1879
- Last known activity
- Dec 5, 2023